Patents by Inventor Jung-Hye Choi

Jung-Hye Choi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9504724
    Abstract: The present invention relates to a pharmaceutical composition containing Puerariae Flos extracts as active ingredients for preventing or treating endometriosis and the complications thereof. More particularly, Puerariae Flos extracts exhibit the activity of inhibiting the migration and adhesion of endometriosis cells, inhibiting the expressions of MMP-2 and MMP-9, which are factors associated with migration and adhesion, inhibiting the expression of COX-2, which is a factor associated with pain, and inhibiting the expression of MCP-1, which is a cytokine associated with inflammation, and RANTES. Therefore, the Puerariae Flos extracts of the present invention can be effectively used as active ingredients for a pharmaceutical composition for preventing and treating endometriosis and the complications thereof, and for a health food.
    Type: Grant
    Filed: September 24, 2012
    Date of Patent: November 29, 2016
    Assignee: University-Industry Cooperation Group of Kyung-Hee University
    Inventors: Jung-Hye Choi, Ji-Hyyun Kim
  • Publication number: 20160108390
    Abstract: The present invention relates to a composition for stabilizing extracellular superoxide dismutase (EC-SOD) protein and a method for stabilizing EC-SOD protein using the composition. More particularly, the present invention relates to a composition for stabilizing EC-SOD protein comprising bovine serum albumin (BSA), human serum albumin (HSA), polyethylene glycol (PEG) or fetal bovine serum (FBS) as an effective ingredient; a method for stabilizing EC-SOD protein using the inventive composition; and a method for preparing a stabilized EC-SOD protein using the inventive composition. The present invention provides a composition for stabilizing EC-SOD protein and a method for stabilizing EC-SOD using the inventive composition in order to use EC-SOD protein for clinical or non-clinical purposes. Further, the present invention attributes to the obtainment of stabilized EC-SOD protein, leading to its applicability in various medicinal and cosmetic fields.
    Type: Application
    Filed: May 26, 2015
    Publication date: April 21, 2016
    Inventors: Tae-Yoon KIM, Sunghwan Kim, Hae-Young Kim, Jung-Ho Kim, Jung-Hye Choi, Won-Kook Ham, Yoon-Jae Jeon
  • Patent number: 9301943
    Abstract: The present invention provides a medicinal and/or a food usage of eupatilin for treating, improving, and/or preventing at least one condition selected from bone disease, menopausal disorder, cardiovascular disease, neurodegenerative disease, or obesity. Advantages of the present invention includes little or no possibility of side effects such as cancer, and effective treatment, improvement, and/or prevention of the at least one condition selected from bone disease, menopausal disorder, cardiovascular disease, neurodegenerative disease, and obesity.
    Type: Grant
    Filed: September 27, 2012
    Date of Patent: April 5, 2016
    Assignee: UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
    Inventors: Jung-Hye Choi, Kyung-Tae Lee, Ji-Hyun Kim, Nam-In Baek
  • Publication number: 20140288168
    Abstract: The present invention provides a medicinal and/or a food usage of eupatilin for treating, improving, and/or preventing at least one condition selected from bone disease, menopausal disorder, cardiovascular disease, neurodegenerative disease, or obesity. Advantages of the present invention includes little or no possibility of side effects such as cancer, and effective treatment, improvement, and/or prevention of the at least one condition selected from bone disease, menopausal disorder, cardiovascular disease, neurodegenerative disease, and obesity.
    Type: Application
    Filed: September 27, 2012
    Publication date: September 25, 2014
    Inventors: Jung-Hye Choi, Kyung-Tae Lee, Ji-Hyun Kim, Nam-In Baek
  • Publication number: 20140234451
    Abstract: The present invention relates to a pharmaceutical composition containing Puerariae Flos extracts as active ingredients for preventing or treating endometriosis and the complications thereof. More particularly, Puerariae Flos extracts exhibit the activity of inhibiting the migration and adhesion of endometriosis cells, inhibiting the expressions of MMP-2 and MMP-9, which are factors associated with migration and adhesion, inhibiting the expression of COX-2, which is a factor associated with pain, and inhibiting the expression of MCP-1, which is a cytokine associated with inflammation, and RANTES. Therefore, the Puerariae Flos extracts of the present invention can be effectively used as active ingredients for a pharmaceutical composition for preventing and treating endometriosis and the complications thereof, and for a health food.
    Type: Application
    Filed: September 24, 2012
    Publication date: August 21, 2014
    Applicant: University-Industry Cooperation Group of Kyung Hee University
    Inventors: Jung-Hye Choi, Ji-Hyyun Kim